RIO DE JANEIRO, BRAZIL - The National Health Surveillance Agency (ANVISA) approved on Tuesday the marketing of medicines made from cannabis, the substance of marijuana, for medicinal use in pharmacies in Brazil. The measure was approved unanimously. It becomes effective 90 days after its publication in the Federal Gazette and is valid for three years, at which time it may be reviewed.
Also on Tuesday, the Agency vetoed the proposal to authorize the planting and cultivation of . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here